Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

LL-37 Antimicrobial Complete Guide 2026: Research Applications Comparison

In vitro antimicrobial assays (MIC determination) 1–32 μg/mL Bacterial growth inhibition; membrane disruption visible via electron microscopy Use cation-adjusted Mueller-Hinton broth to prevent ionic interference; read MIC at 16–18 hours Standard first-line sc

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • In vitro antimicrobial assays (MIC determination)
  • 1–32 μg/mL
  • Bacterial growth inhibition; membrane disruption visible via electron microscopy
  • Use cation-adjusted Mueller-Hinton broth to prevent ionic interference; read MIC at 16–18 hours
  • Standard first-line screen for antimicrobial efficacy—reliable, reproducible, and directly comparable to antibiotic controls
  • Biofilm disruption studies
  • 10–50 μg/mL
  • Biofilm biomass reduction; disruption of extracellular polymeric substance (EPS) matrix
  • Combine LL-37 with crystal violet staining or confocal microscopy; measure at 24–48 hours post-treatment
  • Higher concentrations required vs planktonic bacteria—biofilm matrix shields cells from peptide contact
  • Wound healing models (in vitro scratch assays)
  • 0.5–5 μg/mL
  • Accelerated keratinocyte migration; increased wound closure rates by 40–60%
  • Use serum-free media to isolate LL-37 effect; measure closure at 12–24 hour intervals
  • Low-dose LL-37 drives proliferation without cytotoxicity—ideal range for tissue regeneration research
  • Endotoxin neutralization assays
  • 2–10 μg/mL
  • Reduced LPS-induced cytokine release (TNF-α, IL-6) in macrophage cultures
  • Pre-incubate LL-37 with LPS for 30 minutes before adding to cells; measure cytokines via ELISA
  • LL-37 binds lipid A domain—this is a direct chemical interaction, not an enzymatic process
  • Synergy testing with antibiotics
  • 0.5–4 μg/mL LL-37 + subinhibitory antibiotic
  • Fractional inhibitory concentration index (FICI) <0.5 indicates synergy
  • Use checkerboard dilution method; calculate FICI from combined MIC reductions
  • LL-37 enhances membrane permeability—allows antibiotics to penetrate bacterial cells more effectively